NJ Biopharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
675 US Highway 1 Ste B129, North Brunswi...Phone Number
(732) 202-5664Website
www.njbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About NJ Biopharmaceuticals
NJ Bio, Inc. is a Contract Research Organization that specializes in providing integrated chemistry and biology services to biopharmaceutical and chemistry-based technology companies. Their extensive service offerings include ADC services, bioconjugation, high-throughput screening, and custom synthesis, among others. The company aims to deliver affordable, timely, and customizable solutions to meet a wide range of discovery and development research needs. NJ Bio is recognized for its expertise and commitment to quality, making it a preferred partner for various biotech firms.Explore more
NJ Biopharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NJ Biopharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once NJ Biopharmaceuticals has new funding data
Check if NJ Biopharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if NJ Biopharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if NJ Biopharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NJ Biopharmaceuticals
Product Launch: Get notified when NJ Biopharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NJ Biopharmaceuticals recently announced quarterly report
NJ Biopharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined NJ Biopharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to NJ Biopharmaceuticals
Compare insights from companies similar to NJ Biopharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NJ Biopharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NJ Biopharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NJ Biopharmaceuticals.
NJ Biopharmaceuticals Tech Stack
A closer look at the technologies used by NJ Biopharmaceuticals
Most Recent Scoops
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Promotion
Executive Move
NJ Biopharmaceuticals has announced that Naresh Jain has been promoted to the role of Chief Executive Officer.
Event
Events
Event
Events
Open Position
NJ Biopharmaceuticals News & Media
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
PRINCETON, N.J. and TOKYO, March 31, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"), a leading provider of biopharmaceutical manufacturing services and platform...Suven Pharma Acquires Majority Stake in NJ Bio to Expand ADC/XDC Capabilities
Suven Pharmaceuticals Limited has announced the acquisition of a 56% stake in NJ Bio Inc for $64.4 million, enhancing its R&D and manufacturing footprint in the antibody drug conjugate market, projected to grow rapidly.Suven Pharmaceuticals acquires controlling stake in NJ Bio for USD 64.4 million
Suven Pharmaceuticals Limited, a leading CDMO specialising in innovative drug modalities, has acquired a 56 per cent controlling stake in NJ Bio Inc., an ADC-focused CRDMO based in Princeton, for USD 64.4 million.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NJ Biopharmaceuticals
Sign Up For FreeTo access detailed company insights
NJ Bio, Inc. is a Contract Research Organization that specializes in providing integrated chemistry and biology services to biopharmaceutical and chemistry-based technology companies. Their extensive service offerings include ADC services, bioconjugation, high-throughput screening, and custom synthesis, among others. The company aims to deliver aff... Read More
